The ventilator named 'SwasthVayu' is the culmination ofefforts of team of technocrats, medical practitioners andscientists at NAL, who worked relentlessly amid thelockdown.
The major advantage of this device was that it was simpleto use without any specialized nursing, cost effective,compact and configured with majority of indigenous components,the premier aerospace lab of the Council of Scientific andIndustrial Research said in a release.
It was ideal for treating COVID -19 patients in wards,make-shift hospitals, dispensaries and home in current Indianscenario.
CSIR-NAL is in process of taking it forward with theregulatory authorities for the approval and expected to getshortly, it said adding that the dialogue has already beeninitiated with major public and private industries as apartner for mass production.
The system has been certified for safety and performanceby NABL accredited agencies and has undergone stringentbiomedical tests and beta clinical trials at NAL HealthCentre.
Director of CSIR-NAL, Jitendra J Jadhav said based onglobal experience and specific inputs from pulmonologists inIndia and abroad, the lab has developed the BiPAP non invasiveventilator.
The ventilator is equipped with an externally connectedoxygen concentrator which will be ideal to treat moderate ormid-stage severe COVID-19 patients, who do not requireintubation and invasive ventilation.
CSIR NAL has enabled a spin-off technology based on itsexpertise in the aerospace design domain, the release said. KSUROH ROH